Cochlear Ltd (COH), the world's top hearing implants maker, met its market guidance to post a net income of A$188.9 million ($144.53 million) for the year to June 30, an increase of 30 percent.
The Sydney-based maker of two-thirds of hearing implants sold globally said sales revenue grew 23 percent to A$1.158 billion, exceeding A$1 billion for the first time.
Sales revenue in the Asia Pacific region grew 31 percent, benefiting from Chinese government tenders that Cochlear supplied, the company said in a statement.
A year ago, the company missed market expectations and cut its dividend while still handling the fallout from a voluntary product recall in 2011. ($1 = 1.3070 Australian dollars)
News: Australia's Cochlear meets guidance with 30 pct profit rise
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$302.90 |
Change
-0.880(0.29%) |
Mkt cap ! $19.80B | |||
| Open | High | Low | Value | Volume |
| $303.14 | $304.94 | $300.54 | $8.921M | 29.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4 | $302.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $302.90 | 9 | 3 |
View Market Depth
| Last trade - 13.16pm 22/08/2025 (20 minute delay) ? |
| COH (ASX) Chart |